866-997-4948(US-Canada Toll Free)

Global Antihypertensive Market Professional Survey Report 2018

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 109 Pages

This report studies the global Antihypertensive market status and forecast, categorizes the global Antihypertensive market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.
Antihypertensives are the drugs that are used to treat high blood pressure. This type of drug alleviate the complications of stroke and myocardial infarction.

The global Antihypertensive market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
Pfizer
Novartis
Sanofi
Merck
Boehringer Ingelheim
Lupin
Johnson & Johnson
Astra Zeneca
Daiichi Sankyo
Ranbaxy

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diuretics
Angiotensin receptor blockers (ARBs)
Angiotensin converting enzyme (ACE) inhibitors
Beta blockers
Alpha blockers
Calcium channel blockers
Renin inhibitors
Vasodilators

By Application, the market can be split into
Hosptial
Clinic
Home

The study objectives of this report are:
To analyze and study the global Antihypertensive capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Antihypertensive manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antihypertensive are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Antihypertensive Manufacturers
Antihypertensive Distributors/Traders/Wholesalers
Antihypertensive Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Antihypertensive market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Antihypertensive Market Professional Survey Report 2018
1 Industry Overview of Antihypertensive
1.1 Definition and Specifications of Antihypertensive
1.1.1 Definition of Antihypertensive
1.1.2 Specifications of Antihypertensive
1.2 Classification of Antihypertensive
1.2.1 Diuretics
1.2.2 Angiotensin receptor blockers (ARBs)
1.2.3 Angiotensin converting enzyme (ACE) inhibitors
1.2.4 Beta blockers
1.2.5 Alpha blockers
1.2.6 Calcium channel blockers
1.2.7 Renin inhibitors
1.2.8 Vasodilators
1.3 Applications of Antihypertensive
1.3.1 Hosptial
1.3.2 Clinic
1.3.3 Home
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Antihypertensive
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antihypertensive
2.3 Manufacturing Process Analysis of Antihypertensive
2.4 Industry Chain Structure of Antihypertensive

3 Technical Data and Manufacturing Plants Analysis of Antihypertensive
3.1 Capacity and Commercial Production Date of Global Antihypertensive Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Antihypertensive Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Antihypertensive Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Antihypertensive Major Manufacturers in 2017

4 Global Antihypertensive Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Antihypertensive Capacity and Growth Rate Analysis
4.2.2 2017 Antihypertensive Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Antihypertensive Sales and Growth Rate Analysis
4.3.2 2017 Antihypertensive Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Antihypertensive Sales Price
4.4.2 2017 Antihypertensive Sales Price Analysis (Company Segment)

5 Antihypertensive Regional Market Analysis
5.1 North America Antihypertensive Market Analysis
5.1.1 North America Antihypertensive Market Overview
5.1.2 North America 2013-2018E Antihypertensive Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Antihypertensive Sales Price Analysis
5.1.4 North America 2017 Antihypertensive Market Share Analysis
5.2 Europe Antihypertensive Market Analysis
5.2.1 Europe Antihypertensive Market Overview
5.2.2 Europe 2013-2018E Antihypertensive Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Antihypertensive Sales Price Analysis
5.2.4 Europe 2017 Antihypertensive Market Share Analysis
5.3 China Antihypertensive Market Analysis
5.3.1 China Antihypertensive Market Overview
5.3.2 China 2013-2018E Antihypertensive Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Antihypertensive Sales Price Analysis
5.3.4 China 2017 Antihypertensive Market Share Analysis
5.4 Japan Antihypertensive Market Analysis
5.4.1 Japan Antihypertensive Market Overview
5.4.2 Japan 2013-2018E Antihypertensive Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Antihypertensive Sales Price Analysis
5.4.4 Japan 2017 Antihypertensive Market Share Analysis
5.5 Southeast Asia Antihypertensive Market Analysis
5.5.1 Southeast Asia Antihypertensive Market Overview
5.5.2 Southeast Asia 2013-2018E Antihypertensive Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Antihypertensive Sales Price Analysis
5.5.4 Southeast Asia 2017 Antihypertensive Market Share Analysis
5.6 India Antihypertensive Market Analysis
5.6.1 India Antihypertensive Market Overview
5.6.2 India 2013-2018E Antihypertensive Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Antihypertensive Sales Price Analysis
5.6.4 India 2017 Antihypertensive Market Share Analysis

6 Global 2013-2018E Antihypertensive Segment Market Analysis (by Type)
6.1 Global 2013-2018E Antihypertensive Sales by Type
6.2 Different Types of Antihypertensive Product Interview Price Analysis
6.3 Different Types of Antihypertensive Product Driving Factors Analysis
6.3.1 Diuretics Growth Driving Factor Analysis
6.3.2 Angiotensin receptor blockers (ARBs) Growth Driving Factor Analysis
6.3.3 Angiotensin converting enzyme (ACE) inhibitors Growth Driving Factor Analysis
6.3.4 Beta blockers Growth Driving Factor Analysis
6.3.5 Alpha blockers Growth Driving Factor Analysis
6.3.6 Calcium channel blockers Growth Driving Factor Analysis
6.3.7 Renin inhibitors Growth Driving Factor Analysis
6.3.8 Vasodilators Growth Driving Factor Analysis

7 Global 2013-2018E Antihypertensive Segment Market Analysis (by Application)
7.1 Global 2013-2018E Antihypertensive Consumption by Application
7.2 Different Application of Antihypertensive Product Interview Price Analysis
7.3 Different Application of Antihypertensive Product Driving Factors Analysis
7.3.1 Hosptial of Antihypertensive Growth Driving Factor Analysis
7.3.2 Clinic of Antihypertensive Growth Driving Factor Analysis
7.3.3 Home of Antihypertensive Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Antihypertensive
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Pfizer 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2017 Antihypertensive Business Region Distribution Analysis
8.2 Novartis
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Novartis 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Novartis 2017 Antihypertensive Business Region Distribution Analysis
8.3 Sanofi
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Sanofi 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Sanofi 2017 Antihypertensive Business Region Distribution Analysis
8.4 Merck
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Merck 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Merck 2017 Antihypertensive Business Region Distribution Analysis
8.5 Boehringer Ingelheim
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Boehringer Ingelheim 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Boehringer Ingelheim 2017 Antihypertensive Business Region Distribution Analysis
8.6 Lupin
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Lupin 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Lupin 2017 Antihypertensive Business Region Distribution Analysis
8.7 Johnson & Johnson
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Johnson & Johnson 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Johnson & Johnson 2017 Antihypertensive Business Region Distribution Analysis
8.8 Astra Zeneca
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Astra Zeneca 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Astra Zeneca 2017 Antihypertensive Business Region Distribution Analysis
8.9 Daiichi Sankyo
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Daiichi Sankyo 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Daiichi Sankyo 2017 Antihypertensive Business Region Distribution Analysis
8.10 Ranbaxy
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Ranbaxy 2017 Antihypertensive Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Ranbaxy 2017 Antihypertensive Business Region Distribution Analysis

9 Development Trend of Analysis of Antihypertensive Market
9.1 Global Antihypertensive Market Trend Analysis
9.1.1 Global 2018-2025 Antihypertensive Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Antihypertensive Sales Price Forecast
9.2 Antihypertensive Regional Market Trend
9.2.1 North America 2018-2025 Antihypertensive Consumption Forecast
9.2.2 Europe 2018-2025 Antihypertensive Consumption Forecast
9.2.3 China 2018-2025 Antihypertensive Consumption Forecast
9.2.4 Japan 2018-2025 Antihypertensive Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Antihypertensive Consumption Forecast
9.2.6 India 2018-2025 Antihypertensive Consumption Forecast
9.3 Antihypertensive Market Trend (Product Type)
9.4 Antihypertensive Market Trend (Application)

10 Antihypertensive Marketing Type Analysis
10.1 Antihypertensive Regional Marketing Type Analysis
10.2 Antihypertensive International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antihypertensive by Region
10.4 Antihypertensive Supply Chain Analysis

11 Consumers Analysis of Antihypertensive
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Antihypertensive Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures
Figure Picture of Antihypertensive
Table Product Specifications of Antihypertensive
Table Classification of Antihypertensive
Figure Global Production Market Share of Antihypertensive by Type in 2017
Figure Diuretics Picture
Table Major Manufacturers of Diuretics
Figure Angiotensin receptor blockers (ARBs) Picture
Table Major Manufacturers of Angiotensin receptor blockers (ARBs)
Figure Angiotensin converting enzyme (ACE) inhibitors Picture
Table Major Manufacturers of Angiotensin converting enzyme (ACE) inhibitors
Figure Beta blockers Picture
Table Major Manufacturers of Beta blockers
Figure Alpha blockers Picture
Table Major Manufacturers of Alpha blockers
Figure Calcium channel blockers Picture
Table Major Manufacturers of Calcium channel blockers
Figure Renin inhibitors Picture
Table Major Manufacturers of Renin inhibitors
Figure Vasodilators Picture
Table Major Manufacturers of Vasodilators
Table Applications of Antihypertensive
Figure Global Consumption Volume Market Share of Antihypertensive by Application in 2017
Figure Hosptial Examples
Table Major Consumers in Hosptial
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Home Examples
Table Major Consumers in Home
Figure Market Share of Antihypertensive by Regions
Figure North America Antihypertensive Market Size (Million USD) (2013-2025)
Figure Europe Antihypertensive Market Size (Million USD) (2013-2025)
Figure China Antihypertensive Market Size (Million USD) (2013-2025)
Figure Japan Antihypertensive Market Size (Million USD) (2013-2025)
Figure Southeast Asia Antihypertensive Market Size (Million USD) (2013-2025)
Figure India Antihypertensive Market Size (Million USD) (2013-2025)
Table Antihypertensive Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antihypertensive in 2017
Figure Manufacturing Process Analysis of Antihypertensive
Figure Industry Chain Structure of Antihypertensive
Table Capacity and Commercial Production Date of Global Antihypertensive Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Antihypertensive Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Antihypertensive Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Antihypertensive Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Antihypertensive 2013-2018E
Figure Global 2013-2018E Antihypertensive Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Antihypertensive Market Size (Value) and Growth Rate
Table 2013-2018E Global Antihypertensive Capacity and Growth Rate
Table 2017 Global Antihypertensive Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Antihypertensive Sales (K Units) and Growth Rate
Table 2017 Global Antihypertensive Sales (K Units) List (Company Segment)
Table 2013-2018E Global Antihypertensive Sales Price (USD/Unit)
Table 2017 Global Antihypertensive Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Antihypertensive 2013-2018E
Figure North America 2013-2018E Antihypertensive Sales Price (USD/Unit)
Figure North America 2017 Antihypertensive Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Antihypertensive 2013-2018E
Figure Europe 2013-2018E Antihypertensive Sales Price (USD/Unit)
Figure Europe 2017 Antihypertensive Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Antihypertensive 2013-2018E
Figure China 2013-2018E Antihypertensive Sales Price (USD/Unit)
Figure China 2017 Antihypertensive Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Antihypertensive 2013-2018E
Figure Japan 2013-2018E Antihypertensive Sales Price (USD/Unit)
Figure Japan 2017 Antihypertensive Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Antihypertensive 2013-2018E
Figure Southeast Asia 2013-2018E Antihypertensive Sales Price (USD/Unit)
Figure Southeast Asia 2017 Antihypertensive Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Antihypertensive 2013-2018E
Figure India 2013-2018E Antihypertensive Sales Price (USD/Unit)
Figure India 2017 Antihypertensive Sales Market Share
Table Global 2013-2018E Antihypertensive Sales (K Units) by Type
Table Different Types Antihypertensive Product Interview Price
Table Global 2013-2018E Antihypertensive Sales (K Units) by Application
Table Different Application Antihypertensive Product Interview Price
Table Pfizer Information List
Table Product Overview
Table 2017 Pfizer Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Pfizer Antihypertensive Business Region Distribution
Table Novartis Information List
Table Product Overview
Table 2017 Novartis Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Novartis Antihypertensive Business Region Distribution
Table Sanofi Information List
Table Product Overview
Table 2017 Sanofi Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Sanofi Antihypertensive Business Region Distribution
Table Merck Information List
Table Product Overview
Table 2017 Merck Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Merck Antihypertensive Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product Overview
Table 2017 Boehringer Ingelheim Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Boehringer Ingelheim Antihypertensive Business Region Distribution
Table Lupin Information List
Table Product Overview
Table 2017 Lupin Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Lupin Antihypertensive Business Region Distribution
Table Johnson & Johnson Information List
Table Product Overview
Table 2017 Johnson & Johnson Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Johnson & Johnson Antihypertensive Business Region Distribution
Table Astra Zeneca Information List
Table Product Overview
Table 2017 Astra Zeneca Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Astra Zeneca Antihypertensive Business Region Distribution
Table Daiichi Sankyo Information List
Table Product Overview
Table 2017 Daiichi Sankyo Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Daiichi Sankyo Antihypertensive Business Region Distribution
Table Ranbaxy Information List
Table Product Overview
Table 2017 Ranbaxy Antihypertensive Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Ranbaxy Antihypertensive Business Region Distribution
Figure Global 2018-2025 Antihypertensive Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Antihypertensive Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Antihypertensive Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Antihypertensive Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Antihypertensive Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Antihypertensive Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Antihypertensive Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Antihypertensive Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Antihypertensive Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Antihypertensive by Type 2018-2025
Table Global Consumption Volume (K Units) of Antihypertensive by Application 2018-2025
Table Traders or Distributors with Contact Information of Antihypertensive by Region

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *